The efficacy of NMP22 in screening for early bladder cancer

被引：0
|
作者：
Abeysekera, W. M. [1 ]
Patel, S. [1 ]
Chinegwundoh, F. [1 ]
Khattak, A. [1 ]
机构：
[1] Newham Univ Hosp, London, England
来源：
BRITISH JOURNAL OF SURGERY | 2013年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [41] Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder
    Sawczuk, IS
    Bagiella, E
    Sawczuk, AT
    Yun, EJ
    CANCER DETECTION AND PREVENTION, 2000, 24 (04): : 364 - 368
  • [42] DIAGNOSIS OF BLADDER CANCER BY COMBINED DETECTION OF MINICHROMOSOME MAINTENANCE 5 PROTEIN AND NMP22 IN URINE
    Dudderidge, T. J.
    Kelly, J.
    Wollenschlaeger, A.
    Leung, H.
    Okoturo, O.
    Prevost, T.
    Prevost, T.
    Robson, W.
    Vasdev, N.
    Pickard, R.
    Stoeber, K.
    Williams, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 73 - 74
  • [43] Urinary NMP22™ and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer
    Witjes, JA
    van der Poel, HG
    van Balken, MR
    Debruyne, FMJ
    Schalken, JA
    EUROPEAN UROLOGY, 1998, 33 (04) : 387 - 391
  • [44] Can nomograms using urinary NMP22 predict recurrence and progression of superficial bladder cancer?
    Mellon, JK
    NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (08): : 370 - 371
  • [45] Can nomograms using urinary NMP22 predict recurrence and progression of superficial bladder cancer?
    J Kilian Mellon
    Nature Clinical Practice Urology, 2005, 2 : 370 - 371
  • [46] Validation of the diagnostic value of NMP22® BladderChek® test as a marker for bladder cancer by photodynamic diagnosis
    Tritschler, Stefan
    Scharf, Sonja
    Karl, Alexander
    Tilki, Derya
    Knuechel, Ruth
    Hartmann, Arndt
    Stief, Christian G.
    Zaak, Dirk
    EUROPEAN UROLOGY, 2007, 51 (02) : 403 - 408
  • [47] NMP22-BladderChek in early bladder cancer detection
    Peter, Oehr
    TUMOR BIOLOGY, 2006, 27 : 46 - 46
  • [48] Urinary nuclear matrix protein 22 (NMP22) as a marker for screening urothelial cancer in patients with microscopic hematuria
    Miyanaga, N
    Akaza, H
    Tsukamoto, T
    Ishikawa, S
    Noguchi, R
    Ohtani, M
    Kawabe, K
    Kubota, Y
    Fujita, K
    Obata, K
    Hirao, Y
    Kotake, T
    Ohmori, H
    Kumazawa, J
    Koiso, K
    JOURNAL OF UROLOGY, 1998, 159 (05): : 243 - 243
  • [49] Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder
    Chahal, R
    Darshane, A
    Browning, AJ
    Sundaram, SK
    EUROPEAN UROLOGY, 2001, 40 (04) : 415 - 420
  • [50] Nuclear matrix protein 22 (NMP22):: A tumor marker in primary diagnosis and follow up of bladder cancer.
    Lüdecke, G
    Farkas, P
    Edler, M
    Kraus, S
    Miller, J
    Fischer, C
    Weidner, W
    JOURNAL OF UROLOGY, 1998, 159 (05): : 244 - 244
12345